Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome (Q46495618)
Jump to navigation
Jump to search
scientific article published in May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome |
scientific article published in May 2005 |
Statements
1 reference
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome (English)
1 reference
1 reference
1 reference
Sibilla Salvadeo
1 reference
Ilaria Ferrari
1 reference
Leonardina Ciccarelli
1 reference
Mario N Piccinni
1 reference
Emmanouil Peros
1 reference
Antonio V Gaddi
1 reference
Morena Ghelfi
1 reference
1 May 2005
1 reference
1 reference
25
1 reference
5
1 reference
637-645
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference